PNMA1 and hepatocellular carcinoma: Liu et al. (2018[20]) determined that miR-33a-5p negatively regulated the expression of PNMA1 to control the cell proliferation in hepatocellular carcinoma (HCC) via the Wnt/β-catenin pathway.